Answers are grounded in this paper and cite their sources.
Despite advancements in diabetes treatment, the management of Painful Diabetic Neuropathy (PDN) remains challenging. Our previous research indicated a significant correlation between the expression and distribution of Aquaporin-4 (AQP4) in the spinal glymphatic system and PDN. However, the potential role and mechanism of liquiritin in PDN treatment remain uncertain.
No takes yet. Share an insight, caveat, or question.
Jia et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: